The NCTY chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the NCTY chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The NCTY stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
View NCTY Detailed Price Forecast - CNN Money | View NCTY Detailed Summary - Google Finance | ||
View NCTY Detailed Summary - Yahoo! Finance | View NCTY Stock Research & Analysis - Zacks.com |
View NCTY Trends & Analysis - Trade-Ideas | View NCTY Major Holders - Barrons | ||
View NCTY Call Transcripts - NASDAQ | View NCTY Breaking News & Analysis - Seeking Alpha | ||
View NCTY Annual Report - CompanySpotlight.com | View NCTY OTC Short Report - OTCShortReport.com | ||
View NCTY Fundamentals - TradeKing | View NCTY SEC Filings - Bar Chart | ||
View Historical Prices for NCTY - The WSJ | View Performance/Total Return for NCTY - Morningstar | ||
View the Analyst Estimates for NCTY - MarketWatch | View the Earnings History for NCTY - CNBC | ||
View the NCTY Earnings - StockMarketWatch | View NCTY Buy or Sell Recommendations - MacroAxis | ||
View the NCTY Bullish Patterns - American Bulls | View NCTY Short Pain Metrics - ShortPainBot.com |
View NCTY Stock Mentions - StockTwits | View NCTY Stock Mentions - PennyStockTweets | ||
View NCTY Stock Mentions - Twitter | View NCTY Investment Forum News - Investor Hub | ||
View NCTY Stock Mentions - Yahoo! Message Board | View NCTY Stock Mentions - Seeking Alpha |
View Insider Transactions for NCTY - SECform4.com | View Insider Transactions for NCTY - Insider Cow | ||
View NCTY Major Holdings Summary - CNBC | View Insider Disclosure for NCTY - OTC Markets | ||
View Insider Transactions for NCTY - Yahoo! Finance | View Institutional Holdings for NCTY - NASDAQ |
View NCTY Stock Insight & Charts - FinViz.com | View NCTY Investment Charts - StockCharts.com | ||
View NCTY Stock Overview & Charts - BarChart | View NCTY User Generated Charts - Trading View |
The9 Full Year 2023 Earnings: CN¥40.61 loss per share (vs CN¥406 loss in FY 2022)
Posted on Thursday April 18, 2024
The9 ( NASDAQ:NCTY ) Full Year 2023 Results Key Financial Results Revenue: CN¥179.0m (up 51% from FY 2022). Net loss...
The9 Limited Achieved 66% Increase in Net Revenues and Turned Net Loss into Net Income for the Year Ended December 31, 2023
Posted on Monday April 15, 2024
The9 Limited (NASDAQ: NCTY) ("The9"), an established Internet company, today announced it filed its annual report on Form 20-F for the year ended December 31, 2023 with the United States Securities and Exchange Commission ("SEC"). The annual report, which contains The9's audited financial statements, can be assessed on the SEC's website at http://www.sec.gov as well as on the Investor Relations section of The9's website at http://www.the9.com.
A New Generation of Antidepressant Drug Precision Treatment Based on Revolutionary AI Technology is Born
Posted on Monday April 15, 2024
The9 Limited (Nasdaq: NCTY) ("The9"), an established Internet company, today announced that its investee WM Therapeutics Co., Ltd. (未名脑脑) ("WM Therapeutics") has achieved revolutionary breakthroughs in the proprietarily developed research and development of antidepressant drug precision treatment. WM Therapeutics' GenAI multi-dimensional omics drug clinical research technology has made significant progress in new clinical trial, bringing new hope to depression patients.
/C O R R E C T I O N -- The9 Limited/
Posted on Tuesday March 26, 2024
The9 Limited (Nasdaq: NCTY) ("The9"), an established Internet company, today announced that it signed a definitive share purchase agreement (the "Agreement") with WM Therapeutic Co., Ltd. ("WM Therapeutic"), a company operating Generative AI (GenAI) large language model (LLM) multi-dimensional and multi-omics digital precision medicine platform for brain disease, to purchase an additional 21.7% shares of WM Therapeutic by cash and issuance of The9's restricted shares. The9 had invested 8.3% shar